Literature DB >> 23271411

Detection of donor-derived CMV-specific T cells in cerebrospinal fluid in a case of CMV meningoencephalitis after cord blood stem cell transplantation.

Kazuhiro Ikegame1, Ruri Kato, Tatsuya Fujioka, Masaya Okada, Katsuji Kaida, Shinichi Ishii, Satoshi Yoshihara, Takayuki Inoue, Kyoko Taniguchi, Hiroya Tamaki, Toshihiro Soma, Hiroyasu Ogawa.   

Abstract

Cytomegalovirus (CMV) meningoencephalitis is a rather rare complication after allogeneic stem cell transplantation. We describe here the case of a 59-year-old man with acute myeloid leukemia who developed CMV meningoencephalitis after cord blood transplantation. The patient presented with a sudden onset of neurological symptoms, such as convulsion, on day 37. The analysis of cerebrospinal fluid (CSF) sample revealed an increase in the number of cells, which were of donor (cord blood) origin, consisting mainly of T cells. No bacteria were detected in the CSF sample. Real-time PCR analysis revealed that the CSF sample was positive for CMV, but was negative for HHV-6, adenovirus, or BK virus. The patient was diagnosed with CMV meningoencephalitis and received cidofovir. His neurological symptoms were gradually improved and completely disappeared by day 60. CMV-specific dextramer-positive CD8(+) T cells were detected in the peripheral blood and CSF samples, with the frequency being much higher in the CSF. To our knowledge, this is the first report on the appearance of CMV-specific T cells in CSF samples from a patient with CMV meningoencephalitis. Cord blood-derived CMV-specific T cells may develop early after transplantation, enter the intrathecal compartment, and likely contribute to the regulation of CMV-meningoencephalitis.

Entities:  

Mesh:

Year:  2012        PMID: 23271411     DOI: 10.1007/s12185-012-1231-6

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  10 in total

1.  Early immune reaction after reduced-intensity cord-blood transplantation for adult patients.

Authors:  Yukiko Kishi; Masahiro Kami; Shigesaburo Miyakoshi; Yoshinobu Kanda; Naoko Murashige; Takanori Teshima; Eiji Kusumi; Shigeo Hara; Tomoko Matsumura; Koichiro Yuji; Kazuhiro Masuoka; Atsushi Wake; Shinichi Morinaga; Mineo Kanemaru; Tatsuyuki Hayashi; Yuji Tanaka; Shuichi Taniguchi
Journal:  Transplantation       Date:  2005-07-15       Impact factor: 4.939

2.  Presence of JC virus-specific CTL in the cerebrospinal fluid of PML patients: rationale for immune-based therapeutic strategies.

Authors:  Renaud A Du Pasquier; Patrick Autissier; Yue Zheng; Jims Jean-Jacques; Igor J Koralnik
Journal:  AIDS       Date:  2005-12-02       Impact factor: 4.177

3.  Viral encephalitis after allogeneic stem cell transplantation: a rare complication with distinct characteristics of different causative agents.

Authors:  Martin Schmidt-Hieber; Julie Schwender; Werner J Heinz; Tatjana Zabelina; Jörn S Kühl; Sabine Mousset; Silke Schüttrumpf; Christian Junghanss; Gerda Silling; Nadezda Basara; Stefan Neuburger; Eckhard Thiel; Igor W Blau
Journal:  Haematologica       Date:  2010-09-17       Impact factor: 9.941

Review 4.  CMV central nervous system disease in stem-cell transplant recipients: an increasing complication of drug-resistant CMV infection and protracted immunodeficiency.

Authors:  S M Reddy; D J Winston; M C Territo; G J Schiller
Journal:  Bone Marrow Transplant       Date:  2010-03-01       Impact factor: 5.483

5.  Reduced-intensity conditioning followed by unrelated umbilical cord blood transplantation for advanced hematologic malignancies: rapid engraftment in bone marrow.

Authors:  Mahito Misawa; Shunro Kai; Masaya Okada; Toshiyuki Nakajima; Kaori Nomura; Takeshi Wakae; Akinari Toda; Hisayuki Itoi; Hiroyuki Takatsuka; Takeyoshi Itsukuma; Keisuke Nishioka; Yoshihiro Fujimori; Hiroyasu Ogawa; Hiroshi Hara
Journal:  Int J Hematol       Date:  2006-01       Impact factor: 2.490

6.  Ganciclovir-resistant cytomegalovirus encephalitis in a bone marrow transplant recipient.

Authors:  J E Julin; J H van Burik; W Krivit; C Webb; C J Holman; H B Clark; H H Balfour
Journal:  Transpl Infect Dis       Date:  2002-12       Impact factor: 2.228

7.  Identification of T lymphocytes in simian immunodeficiency virus encephalitis: distribution of CD8+ T cells in association with central nervous system vessels and virus.

Authors:  Woong-Ki Kim; Sarah Corey; Gillian Chesney; Heather Knight; Sherry Klumpp; Christian Wüthrich; Norman Letvin; Igor Koralnik; Andrew Lackner; Ronald Veasey; Kenneth Williams
Journal:  J Neurovirol       Date:  2004-10       Impact factor: 2.643

8.  Enhancement of human immunodeficiency virus (HIV)-specific CD8+ T cells in cerebrospinal fluid compared to those in blood among antiretroviral therapy-naive HIV-positive subjects.

Authors:  Shanmugalakshmi Sadagopal; Shelly L Lorey; Louise Barnett; Rebecca Basham; Laurie Lebo; Husamettin Erdem; Kirsten Haman; Malcolm Avison; Kevin Waddell; David W Haas; Spyros A Kalams
Journal:  J Virol       Date:  2008-08-20       Impact factor: 5.103

9.  Correlations of HHV-6 viral load and plasma IL-6 concentration with HHV-6 encephalitis in allogeneic stem cell transplant recipients.

Authors:  M Ogata; T Satou; R Kawano; S Takakura; K Goto; J Ikewaki; K Kohno; T Ikebe; T Ando; Y Miyazaki; E Ohtsuka; Y Saburi; T Saikawa; J Kadota
Journal:  Bone Marrow Transplant       Date:  2009-05-25       Impact factor: 5.483

10.  An antigen-specific pathway for CD8 T cells across the blood-brain barrier.

Authors:  Ian Galea; Martine Bernardes-Silva; Penny A Forse; Nico van Rooijen; Roland S Liblau; V Hugh Perry
Journal:  J Exp Med       Date:  2007-08-06       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.